Immunotherapy

Triple Negative Breast Cancer: A subtractive approach to treatment

Read more

Taming food-induced immune disorders

Read more

The US continues to lead in oncology approvals

Read more

Genmab looks ahead to next phase of growth

Read more

Long-term strategies for immuno-oncology

Read more

Novel immunotherapy arises from collaboration

Read more

Medigene on a new course

Read more

Using the accelerator and brake to treat cancer

Read more

How Pharma is targeting checkpoint inhibitors

Read more

Immunotherapies start to transform cancer care

Read more